Literature DB >> 13904475

Biological fate of C14-labelled ethyl (3,3-diphenyl-l-methyl-propyl) dimethylammoniumbromide Cetiprin, a monoquaternary ammonium compound.

E HANSSON, C G SCHMITERLOW.   

Abstract

Entities:  

Keywords:  AMMONIUM COMPOUNDS/metabolism; PARASYMPATHOLYTICS/metabolism

Mesh:

Substances:

Year:  1961        PMID: 13904475     DOI: 10.1111/j.1600-0773.1961.tb00330.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  4 in total

1.  Fate of emepronium in man in relation to its pharmacological effects.

Authors:  A Sundwall; J Vessman; B Strindberg
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

2.  Neuromuscular paralysis caused by an overdose of emepronium bromide (Cetiprin).

Authors:  A Ferguson; D A Baker
Journal:  Arch Emerg Med       Date:  1985-06

3.  Clinical trial of emepronium bromide in nocturnal frequency of old age.

Authors:  J C Brocklehurst; J B Dillane; J Fry; P Armitage
Journal:  Br Med J       Date:  1969-04-26

4.  Clinical observations with Cetiprin (emepronium bromide).

Authors:  A Hamvas; I Romics; F Balogh
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.